Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Cancer Immunity, an open access journal of the Cancer Research Institute Cancer Vaccines 2005: Barriers, Endpoints & Opportunities October 5-7, 2005 New York, USA Sponsored by the Cancer Research Institute

Session I: Innate Immunity

  • Session I: Innate Immunity
    Genetic analysis of innate immunity
    Bruce Beutler
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session I: Innate Immunity
    NK cell-mediated tumor immune surveillance
    Mark J. Smyth, Nadeen Zerafa, Erika Cretney, Michele W. L. Teng, Jeremy Swann and Yoshihiro Hayakawa
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session I: Innate Immunity
    The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
    David H. Raulet
    Cancer Immun January 1 2006 6 (Suppl 1)

Session II: Imaging the Immune Response to Infection and Cancer

  • Session II: Imaging the Immune Response to Infection and Cancer
    Complex roles of the immunological synapse
    Andrey S. Shaw
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session II: Imaging the Immune Response to Infection and Cancer
    In vivo visualization of CTL responses in lymph nodes
    Ulrich H. von Andrian
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session II: Imaging the Immune Response to Infection and Cancer
    Dynamic in vivo high resolution imaging of immune cell behavior
    Ronald N. Germain, Alex Y. Huang, Hai Qi, Marcello Chieppa, Maria Rescigno, Jackson Egen, Flora Castellino, Ina Ifrim, Clemens Scheinecker, Gregoire Altan-Bonnet, Anthony Rothfuchs, Alan Sher, Marc Bajénoff, Nicholas Glaichenhaus, Katrin Eichelberg, Ze Wang and Sabine Stoll
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session II: Imaging the Immune Response to Infection and Cancer
    Visualizing inflammatory chemokine-guided recruitment of naive CD8+ T cells to sites of antigen-dependent CD4+ T cell-dendritic cell interaction in situ
    Alex Y. Huang, Flora Castellino, Grégoire Altan-Bonnet, Sabine Stoll, Clemens Scheinecker and Ronald N. Germain
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session II: Imaging the Immune Response to Infection and Cancer
    Leukemia and cancer stem cells
    Irving L. Weissman
    Cancer Immun January 1 2006 6 (Suppl 1)

Session III: Laboratory Monitoring of Human Anti-Tumor Responses

  • Session III: Laboratory Monitoring of Human Anti-Tumor Responses
    In vivo antigen delivery by a Salmonella type III secretion system for therapeutic cancer vaccine development
    Jorge E. Galán, Hiroyoshi Nishikawa, Gabriel Briones, Sacha Gnjatic, Gerd Ritter and Lloyd J. Old
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session III: Laboratory Monitoring of Human Anti-Tumor Responses
    CT antigens, gametogenic recapitulation and tumorigenesis
    Andrew J. Simpson, O. L. Caballero, Achim Jungbluth, Yao-Tseng Chen and Lloyd J. Old
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session III: Laboratory Monitoring of Human Anti-Tumor Responses
    Immune monitoring of T-cell responses to full-length tumor antigens
    Danila Valmori
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session III: Laboratory Monitoring of Human Anti-Tumor Responses
    Evolution of NY-ESO-1 cancer vaccines: Lessons learned
    Kunle Odunsi
    Cancer Immun January 1 2006 6 (Suppl 1)

Session IV: Immunotherapy

  • Session IV: Immunotherapy
    Overcoming obstacles to the generation of T cells for tumor therapy
    Philip Greenberg, William Ho, Matthias Wolfl, Ryan Teague, Junko Morimoto, Michelle Dossett, Juergen Kuball, Yang Yang, Carla Fowler and Joe Blattman
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session IV: Immunotherapy
    Human cancer immunotherapy: progress and problems
    Steven A. Rosenberg
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session IV: Immunotherapy
    Balancing tumor immunity and autoimmunity
    Glenn Dranoff
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session IV: Immunotherapy
    Checkpoint blockade in tumor immunotherapy
    James P. Allison
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session IV: Immunotherapy
    Manipulation of co-signal pathways to enhance cancer vaccines
    Lieping Chen
    Cancer Immun January 1 2006 6 (Suppl 1)

Session V: Tregs and Other Checkpoints

  • Session V: Tregs and Other Checkpoints
    Regulatory T cells in anti-tumor immune response
    Hiroshi Shiku
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session V: Tregs and Other Checkpoints
    Regulatory CD4 T cells
    Alexander Rudensky
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session V: Tregs and Other Checkpoints
    Regulatory T cells in ovarian cancer: biology and therapeutic potential
    Tyler J. Curiel, Brian Barnett, Ilona Kryczek, Pui Cheng and Weiping Zou
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session V: Tregs and Other Checkpoints
    Functional control of regulatory T cells by TLR signaling
    Rongfu Wang
    Cancer Immun January 1 2006 6 (Suppl 1)

Session VI: DCs, CD8s, CD4s, Stem Cells

  • Session VI: DCs, CD8s, CD4s, Stem Cells
    Dendritic cells mobilize NKT lymphocytes as adjuncts and adjuvants for anti-tumor immunity
    Ralph M. Steinman
    Cancer Immun January 1 2006 6 (Suppl 1)

  • Session VI: DCs, CD8s, CD4s, Stem Cells
    T-help, TRAIL, and CTL memory
    Stephen P. Schoenberger, Edith M. Janssen, Nathalie Droin, Edward Lemmens, Thomas Griffith and Douglas Green
    Cancer Immun January 1 2006 6 (Suppl 1)

Closing Remarks

  • Closing Remarks
    Cancer Vaccines 2005: Closing remarks
    Kunle Odunsi
    Cancer Immun January 1 2006 6 (Suppl 1)

Back to top
PreviousNext
Cancer Immunity Archive: 6 (Suppl 1)
January 2006
Volume 6, Issue Suppl 1
  • Table of Contents

Sign up for alerts

Jump to

  • Session I: Innate Immunity
  • Session II: Imaging the Immune Response to Infection and Cancer
  • Session III: Laboratory Monitoring of Human Anti-Tumor Responses
  • Session IV: Immunotherapy
  • Session V: Tregs and Other Checkpoints
  • Session VI: DCs, CD8s, CD4s, Stem Cells
  • Closing Remarks
Advertisement
  • Most Cited
  • Most Read
Loading
  • Activity of Anti-CTLA-4 Isotypes in Antitumor Responses
  • Masters of Immunology
  • Characterization of Murine Syngeneic Tumor Models
  • Extending Reach of Checkpoint Blockade in Pancreatic Cancer
  • Case Report: RNA CAR T Cells
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement